Leyla Raiani
Mar 20, 2012

Mayo Clinic researchers building melanoma vaccine to combat skin cancer

Mayo Clinic researchers have trained mouse immune systems to eradicate skin cancer from within, using a genetic combination of human DNA from melanoma cells and a cousin of the rabies virus. The strategy, called cancer immunotherapy, uses a genetically engineered version of the vesicular stomatitis virus to deliver a broad spectrum of genes derived from melanoma cancer cells directly into tumors. In early studies, 60 percent of tumor-burdened mice were cured in fewer than three months and with minimal side effects. According to a researchers Richard Vile and Jose Pulido, this new technique will help to identify a whole new set of genes that encode antigens that are important in stimulating the immune system to reject cancer.

Companies
1
Patents
1
0 Comments
Related Articles
Kristin Wall
Dec 24, 2011
What can increase your risk of skin cancer? Surviving cancer.
One would hope that, when it comes to developing cancer, lightning doesn’t strike in the same place twice. Yet, unfair... Read More
Ann Conkle
Jan 17, 2012
Treating melanoma with a cream
A prescription cream containing the compound imiquimod has been shown to effectively treat melanoma in mice. Imiquimod has several tumor... Read More
Leyla Raiani
Mar 6, 2012
UCLA scientists uncover mechanism for melanoma drug resistance
UCLA researchers have uncovered how an advanced form of melanoma gets around an inhibitor, Zelboraf, which targets the BRAF gene,... Read More